| Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project. | |
| | |
MedLine Citation:
|
PMID: 10423077 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In 1998 the final results were presented of two large intervention trials in hypertension, the Hypertension Optimal Treatment Study (HOT) and the Captopril Prevention Project (CAPPP). Both were initiated from Sweden although the HOT Study was conducted in 26 countries worldwide and the CAPPP Study in Finland and Sweden. The HOT and CAPPP trials and their principal results will be reviewed briefly here. In addition a brief up-date will be provided of three ongoing intervention trials in hypertension that were also initiated from Sweden: the Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-), the Nordic Diltiazem (NORDIL) Study and the Study on Cognition and Prognosis in Elderly Hypertensives (SCOPE). |
| | |
Authors:
|
L Hansson |
Related Documents
:
|
20386437 - Anesthesia for patients with pulmonary hypertension. 1926147 - Histological study of pulmonary vasculature in fatal cases of persistent pulmonary hype... 3060297 - Influence of hypertension and of antihypertensive drugs on the arterial wall. 3934777 - Pulmonary pathology associated with hypertonic central venous fluid administration. 6731407 - Spontaneous primary dissecting coronary artery aneurysm. report of two cases. 12015847 - Complementary use of computed tomographic angiography in treatment planning for posteri... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical and experimental hypertension (New York, N.Y. : 1993) Volume: 21 ISSN: 1064-1963 ISO Abbreviation: Clin. Exp. Hypertens. Publication Date: 1999 Jul-Aug |
Date Detail:
|
Created Date: 1999-12-01 Completed Date: 1999-12-01 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9305929 Medline TA: Clin Exp Hypertens Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 507-15 Citation Subset: IM |
Affiliation:
|
Department of PublicHealth and Social Sciences: Geriatrics, University of Uppsala, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Adult Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors / therapeutic use Anti-Inflammatory Agents, Non-Steroidal / therapeutic use Aspirin / therapeutic use Blood Pressure* Calcium Channel Blockers / therapeutic use Captopril / therapeutic use Cardiovascular Diseases / mortality, prevention & control* Clinical Trials as Topic Felodipine / therapeutic use Female Humans Hypertension / drug therapy* Isradipine / therapeutic use Male Middle Aged Randomized Controlled Trials as Topic Stroke / prevention & control Sweden |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Calcium Channel Blockers; 50-78-2/Aspirin; 62571-86-2/Captopril; 72509-76-3/Felodipine; 75695-93-1/Isradipine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Implications of the Systolic Hypertension in China trial.
Next Document: An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. Wor...